Jonathan Zhang: Workers and researchers see benefits in GLP-1 access. Companies are weighing the costs
Gavin Yamey: How a Controversial Hepatitis B Study Was Funded by the CDC Amid a Global Swirl of Criticism
Ronnie Chatterji: OpenAI's chief economist says this is what it takes to work on his team at the ChatGPT maker